Epidermal growth factor stimulates substrate-selective protein-tyrosine-phosphatase activity.

ανά Hernández-Sotomayor, S M, Arteaga, C L, Soler, C, Carpenter, G
Έκδοση 1993

Elevated content of the tyrosine kinase substrate phospholipase C-gamma 1 in primary human breast carcinomas.

ανά Arteaga, C L, Johnson, M D, Todderud, G, Coffey, R J, Carpenter, G, Page, D L
Έκδοση 1991

Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible...

ανά Arteaga, C L, Hurd, S D, Winnier, A R, Johnson, M D, Fendly, B M, Forbes, J T
Έκδοση 1993

Blockade of the type I somatomedin receptor inhibits growth of human breast cancer cells in athymic mice.

ανά Arteaga, C L, Kitten, L J, Coronado, E B, Jacobs, S, Kull, F C, Allred, D C, Osborne, C K
Έκδοση 1989

Synergistic interaction of the Neu proto-oncogene product and transforming growth factor alpha in the mammary epithelium of transgenic mice.

ανά Muller, W J, Arteaga, C L, Muthuswamy, S K, Siegel, P M, Webster, M A, Cardiff, R D, Meise, K S, Li, F, Halter, S A, Coffey, R J
Έκδοση 1996

Transforming growth factor alpha protection against drug-induced injury to the rat gastric mucosa in vivo.

ανά Romano, M, Polk, W H, Awad, J A, Arteaga, C L, Nanney, L B, Wargovich, M J, Kraus, E R, Boland, C R, Coffey, R J
Έκδοση 1992

Cytokeratin19 induced by HER2/ERK binds and stabilizes HER2 on cell membranes

ανά Ju, J-h, Oh, S, Lee, K-m, Yang, W, Nam, K S, Moon, H-G, Noh, D-Y, Kim, C G, Park, G, Park, J B, Lee, T, Arteaga, C L, Shin, I
Τόπος έκδοσης Cell Death Differ (2015)

Updated results from MONALEESA-2, a phase III trial of first-line ribociclib plus letrozole versus placebo plus letrozole in hormone receptor-positive, HER2-negative advanced breas...

ανά Hortobagyi, G N, Stemmer, S M, Burris, H A, Yap, Y S, Sonke, G S, Paluch-Shimon, S, Campone, M, Petrakova, K, Blackwell, K L, Winer, E P, Janni, W, Verma, S, Conte, P, Arteaga, C L, Cameron, D A, Mondal, S, Su, F, Miller, M, Elmeliegy, M, Germa, C, O’Shaughnessy, J
Τόπος έκδοσης Ann Oncol (2019)

Ado-trastuzumab emtansine (T-DM1) in patients with HER2-amplified tumors excluding breast and gastric/gastroesophageal junction (GEJ) adenocarcinomas: results from the NCI-MATCH tr...

ανά Jhaveri, K L, Wang, X V, Makker, V, Luoh, S -W, Mitchell, E P, Zwiebel, J A, Sharon, E, Gray, R J, Li, S, McShane, L M, Rubinstein, L V, Patton, D, Williams, P M, Hamilton, S R, Conley, B A, Arteaga, C L, Harris, L N, O’Dwyer, P J, Chen, A P, Flaherty, K T
Τόπος έκδοσης Ann Oncol (2019)

Genomic profiling of ER+ breast cancers after short-term estrogen suppression reveals alterations associated with endocrine resistance

ανά Giltnane, J.M., Hutchinson, K.E., Stricker, T.P., Formisano, L., Young, C.D., Estrada, M.V., Nixon, M.J., Du, L., Sanchez, V., Ericsson, P. Gonzalez, Kuba, M.G., Sanders, M.E., Mu, X.J., Van Allen, E.M., Wagle, N., Mayer, I., Abramson, V., Gómez, H., Rizzo, M., Toy, W., Chandarlapaty, S., Mayer, E.L., Christiansen, J., Murphy, D., Fitzgerald, K., Wang, K., Ross, J.S., Miller, V.A., Stephens, P.J., Yelensky, R., Garraway, L., Shyr, Y., Meszoely, I., Balko, J.M., Arteaga, C.L.
Τόπος έκδοσης Sci Transl Med (2017)